FELIPE
VILARDELL VILLELLAS
CON
![Foto de FELIPE](/img/nophoto.png)
![Foto de Institute Catalá Oncología](/img/noimage_org.png)
Institute Catalá Oncología
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Institute Catalá Oncología (8)
2013
-
Level of HER2 gene amplification predicts response and overall survival in her2-positive advanced gastric cancer treated with trastuzumab
Journal of Clinical Oncology, Vol. 31, Núm. 35, pp. 4445-4452
2012
-
GALV expression enhances the therapeutic efficacy of an oncolytic adenovirus by inducing cell fusion and enhancing virus distribution
Gene Therapy, Vol. 19, Núm. 11, pp. 1048-1057
2007
-
Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer
Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Núm. 1, pp. 276-281
2006
-
EPHB4 and survival of colorectal cancer patients
Cancer Research, Vol. 66, Núm. 18, pp. 8943-8948
-
Ketogenic HMGCS2 is a c-Myc target gene expressed in differentiated cells of human colonic epithelium and down-regulated in colon cancer
Molecular Cancer Research, Vol. 4, Núm. 9, pp. 645-653
2005
-
Polymorphisms in sulfotransferases SULT1A1 and SULT1A2 are not related to colorectal cancer
International Journal of Cancer
-
Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk
Cancer Epidemiology Biomarkers and Prevention, Vol. 14, Núm. 7, pp. 1633-1638
2004
-
Organochlorine exposure and colorectal cancer risk
Environmental Health Perspectives, Vol. 112, Núm. 15, pp. 1460-1466